RASSF7 Polyclonal Antibody

Rabbit Anti-RASSF7 Polyclonal Antibody

Product Specifications

Background

RASSF7, also named as HRAS1 and HRC1, is a member of the RASSF family contain a highly conserved Ras association domain (RalGDS/AF-6 or RA) and function as Ras effectors tumor suppressors. RASSF7, RASSF8, RASSF9 and RASSF10 are four evolutionary conserved proteins that are collectively known as the N-terminal RASSF family. RASSF7 is believed to play an essential role in mitosis. RASSF7 has been shown to influence cell failure to form mitotic spindle and also cause nuclear breakdown and apoptosis. The antibody can recognizes all the 3 isoform of RASS7.

CAS Number

9007-83-4

Product Name Alternative

RASSF7; C11orf13; HRC1; Ras association domain-containing protein 7; HRAS1-related cluster protein 1

Gene ID

8045

Accession Number

Q02833

Reactivity

Human, Mouse

Immunogen

Synthesized peptide derived from the Internal region of human RASSF7 at AA range: 130-210

Clonality

Polyclonal

Tag

Ras association domain-containing protein 7

Applications

IHC, IF, ELISA

Purification Method

The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

Concentration

1 mg/ml

Precautions

The product listed herein is for research use only and is not intended for use in human or clinical diagnosis. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license. We cannot be responsible for patent infringements or other violations that may occur with the use of this product.

Shipping Conditions

Gel pack with blue ice.

Storage Conditions

Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.

Notes

RASSF7 Polyclonal Antibody detects endogenous levels of RASSF7 protein.

Formulation

Liquid solution

Buffer pH

Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

Applications Notes

Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: IHC 1:100-1:300; ELISA 1:5000; IF 1:50-200